课题基金 / 基金详情

BASE CONTRACT: YEAR 1 - PRECLINICAL MEDICATIONS SCREENING IN ALCOHOL PREFERRING RATS. BASE PERIOD (FY-19). PERIOD OF PERFORMANCE: 09/29/19 - 09/28/20.

BASE CONTRACT: YEAR 1 - PRECLINICAL MEDICATIONS SCREENING IN ALCOHOL PREFERRING RATS. BASE PERIOD (FY-19). PERIOD OF PERFORMANCE: 09/29/19 - 09/28/20.
基础合同:第一年 - 在酒精偏好大鼠中进行临床前药物筛选。
批准号:
10227891
负责人:
RICHARD L. BELL, PH.D.
金额:
$38.29万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-29 至 2021-09-28

项目摘要

项目成果

RICHARD L. BELL, PH.D.的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This contract is for the blind efficacy testing of reference compounds and compounds of interest on voluntary alcohol drinking by alcohol preferring P and HAD1 rats and provide analysis of said testing. The contract has an intellectual property clause that is Bayh–Dole Act compliant, while offering protection that is attractive to proprietary compound suppliers. This facilitates our ability to test drugs that may eventually be developed commercially. The preclinical efficacy test are designed to inform decisions about further development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRECLINICAL MEDICATIONS SCREENING
  • 批准号:
    10475556
  • 项目类别:
  • 资助金额:
    $39.03万
  • 财政年份:
    2019
  • 负责人:
    RICHARD L. BELL, PH.D.
  • 依托单位:
PRECLINICAL MEDICATIONS SCREENING
  • 批准号:
    10683912
  • 项目类别:
  • 资助金额:
    $39.77万
  • 财政年份:
    2019
  • 负责人:
    RICHARD L. BELL, PH.D.
  • 依托单位:
EO14042 - PRECLINICAL MEDICATIONS SCREENING IN ALCOHOL PREFERRING RATS
  • 批准号:
    10954022
  • 项目类别:
  • 资助金额:
    $40.5万
  • 财政年份:
    2019
  • 负责人:
    RICHARD L. BELL, PH.D.
  • 依托单位:
BASE CONTRACT: YEAR 1 - PRECLINICAL MEDICATIONS SCREENING IN ALCOHOL PREFERRING RATS. BASE PERIOD (FY-19). PERIOD OF PERFORMANCE: 09/29/19 - 09/28/20.
  • 批准号:
    10037799
  • 项目类别:
  • 资助金额:
    $38.22万
  • 财政年份:
    2019
  • 负责人:
    RICHARD L. BELL, PH.D.
  • 依托单位:
海外基金